Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy. (September 2022)
- Record Type:
- Journal Article
- Title:
- Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy. (September 2022)
- Main Title:
- Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy
- Authors:
- Raschke, F.
Witzmann, K.
Seidlitz, A.
Wesemann, T.
Jentsch, C.
Platzek, I.
van den Hoff, J.
Kotzerke, J.
Beuthien-Baumann, B.
Baumann, M.
Linn, J.
Krause, M.
Troost, E.G.C. - Abstract:
- Highlights: Radiotherapy causes atrophy of the hippocampus, amygdala, putamen, thalamus and pallidum. Atrophy is dose dependant and progressive over time. The hippocampus shows the highest atrophy rates at a given mean dose and time. The caudate shows no significant atrophy. Abstract: Background and purpose: Radiotherapy (RT) is an adjuvant treatment option for glioma patients. Side effects include tissue atrophy, which might be a contributing factor to neurocognitive decline after treatment. The goal of this study was to determine potential atrophy of the hippocampus, amygdala, thalamus, putamen, pallidum and caudate nucleus in glioma patients having undergone magnetic resonance imaging (MRI) before and after RT. Materials and methods: Subcortical volumes were measured using T1-weighted MRI from patients before RT (N = 91) and from longitudinal follow-ups acquired in three-monthly intervals (N = 349). The volumes were normalized to the baseline values, while excluding structures touching the clinical target volume (CTV) or abnormal tissue seen on FLAIR imaging. A multivariate linear effects model was used to determine if time after RT and mean RT dose delivered to the corresponding structures were significant predictors of tissue atrophy. Results: The hippocampus, amygdala, thalamus, putamen, and pallidum showed significant atrophy after RT as function of both time after RT and mean RT dose delivered to the corresponding structure. Only the caudate showed no dose or timeHighlights: Radiotherapy causes atrophy of the hippocampus, amygdala, putamen, thalamus and pallidum. Atrophy is dose dependant and progressive over time. The hippocampus shows the highest atrophy rates at a given mean dose and time. The caudate shows no significant atrophy. Abstract: Background and purpose: Radiotherapy (RT) is an adjuvant treatment option for glioma patients. Side effects include tissue atrophy, which might be a contributing factor to neurocognitive decline after treatment. The goal of this study was to determine potential atrophy of the hippocampus, amygdala, thalamus, putamen, pallidum and caudate nucleus in glioma patients having undergone magnetic resonance imaging (MRI) before and after RT. Materials and methods: Subcortical volumes were measured using T1-weighted MRI from patients before RT (N = 91) and from longitudinal follow-ups acquired in three-monthly intervals (N = 349). The volumes were normalized to the baseline values, while excluding structures touching the clinical target volume (CTV) or abnormal tissue seen on FLAIR imaging. A multivariate linear effects model was used to determine if time after RT and mean RT dose delivered to the corresponding structures were significant predictors of tissue atrophy. Results: The hippocampus, amygdala, thalamus, putamen, and pallidum showed significant atrophy after RT as function of both time after RT and mean RT dose delivered to the corresponding structure. Only the caudate showed no dose or time dependant atrophy. Conversely, the hippocampus was the structure with the highest atrophy rate of 5.2 % after one year and assuming a mean dose of 30 Gy. Conclusion: The hippocampus showed the highest atrophy rates followed by the thalamus and the amygdala. The subcortical structures here found to decrease in volume indicative of radiosensitivity should be the focus of future studies investigating the relationship between neurocognitive decline and RT. … (more)
- Is Part Of:
- Clinical and translational radiation oncology. Volume 36(2022)
- Journal:
- Clinical and translational radiation oncology
- Issue:
- Volume 36(2022)
- Issue Display:
- Volume 36, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 36
- Issue:
- 2022
- Issue Sort Value:
- 2022-0036-2022-0000
- Page Start:
- 99
- Page End:
- 105
- Publication Date:
- 2022-09
- Subjects:
- CSF cerebrospinal fluid -- CT computed tomography -- CTV clinical target volume -- GM grey matter -- GTV gross tumour volume -- MNI Montreal Neurological Institute -- MRI magnetic resonance imaging -- PTV planning target volume -- ROI region of interest -- RT radiotherapy -- T1w T1-weighted -- TBV tumour bed volume -- WM white matter
Hippocampus -- Amygdala -- Radiotherapy -- Atrophy -- Proton therapy -- Caudate
Cancer -- Radiotherapy -- Periodicals
Oncology -- Periodicals
Cancer -- Radiotherapy
Oncology
Radiation Oncology
Neoplasms -- radiotherapy
Translational Medical Research
Periodicals
Electronic journals
Periodicals
616.9940642 - Journal URLs:
- https://www.journals.elsevier.com/clinical-and-translational-radiation-oncology ↗
http://www.sciencedirect.com/science/journal/24056308 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.ctro.2022.07.003 ↗
- Languages:
- English
- ISSNs:
- 2405-6308
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23052.xml